Articles Tagged With:
-
Colorado Program Significantly Reduces Opioid Prescribing in 10 EDs During Six-month Period
A pilot group of 10 EDs in Colorado has shown impressive reductions in opioid prescribing by encouraging the use of alternatives to opioids (ALTO) in the care of five key pain pathways. Between June and November 2017, the pilot sites reduced the use of opioids by 36% when compared to the same six-month period in 2016. The Colorado Hospital Association, which championed the initiative, is moving to expand the ALTO approach used in the pilot to other hospitals in the state.
-
Surgeon General: Clinicians Must End Addiction Stigma, Use Evidence-based Care
During a recent town hall, the surgeon general stressed the importance of recognizing that substance use disorder is a chronic disease that must be treated with the same skill, compassion, and urgency that clinicians use to treat other chronic health conditions.
-
Alarming Increases in ED Visits for Opioid Overdoses Highlight Need for Robust Solutions
While it is clear that more action must be taken to address the problem, some states already have taken steps to respond to the epidemic in a coordinated way.
-
Skin Infestations: Fungal and Scabies
Although cutaneous fungal infections rarely are life-threatening, they are common, and they are irritating. This article provides an in-depth look at common rashes caused by fungi and scabies.
-
What Form of AV Block?
The long lead II rhythm strip shown in the figure was obtained from a hemodynamically stable patient. The rhythm was diagnosed as showing second-degree AV block, Mobitz Type II. Do you agree with that assessment?
-
Clinical Briefs
In this section: comparing GLP-1 agonists; weighing two treatments for extended venous thromboembolism; and considering fracture risks possibly associated with inhaled corticosteroids.
-
Ibalizumab-uiyk Injection (Trogarzo)
Ibalizumab-uiyk, in combination with other antiretrovirals, is indicated for the treatment of HIV-1 in heavily treatment-experienced adults with multidrug-resistant HIV infections failing their current regimens.
-
After Myocardial Infarction, Increased Risk for Ischemic Stroke Persists for 12 Weeks
This study establishes that the elevated short-term risk of stroke extends beyond 30 days and remains elevated for up to 12 weeks following acute myocardial infarction.
-
Stroke Risk in Atrial Fibrillation: A Moving Target?
An investigation of patients in a national database with atrial fibrillation, no comorbidities, and not on aspirin or anticoagulants showed that the clinical features that make up the CHA2DS2-VASc score change over time and can increase a patient’s risk for stroke, which could affect therapy decisions. Thus, the CHA2DS2-VASc score should be reassessed periodically and appropriate therapeutic actions taken promptly.
-
Elderly May Not Benefit From Statins for Primary Prevention
In an examination of the data from the much-publicized Systolic Blood Pressure Intervention Trial (SPRINT), the author found no benefit of statin therapy for primary prevention of cardiovascular events or all-cause mortality.